Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-21-009500
Filing Date
2021-04-23
Accepted
2021-04-23 06:16:29
Documents
66

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm S-1/A 1815309
2 ex10-15.htm EX-10.15 182385
3 ex23-1.htm EX-23.1 3638
4 s-1_001.jpg GRAPHIC 7111
5 img_005.jpg GRAPHIC 122365
6 img_006.jpg GRAPHIC 38429
7 img_003.jpg GRAPHIC 20507
8 img_004.jpg GRAPHIC 17302
  Complete submission text file 0001493152-21-009500.txt   5387847

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE ptix-20201231.xml EX-101.INS 600761
10 XBRL SCHEMA FILE ptix-20201231.xsd EX-101.SCH 44036
11 XBRL CALCULATION FILE ptix-20201231_cal.xml EX-101.CAL 52917
12 XBRL DEFINITION FILE ptix-20201231_def.xml EX-101.DEF 201817
13 XBRL LABEL FILE ptix-20201231_lab.xml EX-101.LAB 346154
14 XBRL PRESENTATION FILE ptix-20201231_pre.xml EX-101.PRE 279764
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-253006 | Film No.: 21846630
SIC: 7389 Services-Business Services, NEC